<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38973985</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2211-8179</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Global heart</Title><ISOAbbreviation>Glob Heart</ISOAbbreviation></Journal><ArticleTitle>A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief.</ArticleTitle><Pagination><StartPage>55</StartPage><MedlinePgn>55</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">55</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/gh.1334</ELocationID><Abstract><AbstractText>The Coronavirus Disease 2019, commonly referred to as COVID-19, is responsible for one of the deadliest pandemics in human history. The direct, indirect and lasting repercussions of the COVID-19 pandemic on individuals and public health, as well as health systems can still be observed, even today. In the midst of the initial chaos, the role of tobacco as a prognostic factor for unfavourable COVID-19 outcomes was largely neglected. As of 2023, numerous studies have confirmed that use of tobacco, a leading risk factor for cardiovascular and other diseases, is strongly associated with increased risks of severe COVID-19 complications (e.g., hospitalisation, ICU admission, need for mechanical ventilation, long COVID, etc.) and deaths from COVID-19. In addition, evidence suggests that COVID-19 directly affects multiple organs beyond the respiratory system, disproportionately impacting individuals with comorbidities. Notably, people living with cardiovascular disease are more prone to experiencing worse outcomes, as COVID-19 often inherently manifests as thrombotic cardiovascular complications. As such, the triad of tobacco, COVID-19 and cardiovascular disease constitutes a dangerous cocktail. The lockdowns and social distancing measures imposed by governments have also had adverse effects on our lifestyles (e.g., shifts in diets, physical activity, tobacco consumption patterns, etc.) and mental well-being, all of which affect cardiovascular health. In particular, vulnerable populations are especially susceptible to tobacco use, cardiovascular disease and the psychological fallout from the pandemic. Therefore, national pandemic responses need to consider health equity as well as the social determinants of health. The pandemic has also had catastrophic impacts on many health systems, bringing some to the brink of collapse. As a result, many health services, such as services for cardiovascular disease or tobacco cessation, were severely disrupted due to fears of transmission and redirection of resources for COVID-19 care. Unfortunately, the return to pre-pandemic levels of cardiovascular disease care activity has stagnated. Nevertheless, digital solutions, such as telemedicine and apps, have flourished, and may help reduce the gaps. Advancing tobacco control was especially challenging due to interference from the tobacco industry. The industry exploited lingering uncertainties to propagate misleading information on tobacco and COVID-19 in order to promote its products. Regrettably, the links between tobacco use and risk of SARS-CoV-2 infection remain inconclusive. However, a robust body of evidence has, since then, demonstrated that tobacco use is associated with more severe COVID-19 illness and complications. Additionally, the tobacco industry also repeatedly attempted to forge partnerships with governments under the guise of corporate social responsibility. The implementation of the WHO Framework Convention on Tobacco Control could address many of the aforementioned challenges and alleviate the burden of tobacco, COVID-19, and cardiovascular disease. In particular, the implementation of Article 5.3 could protect public health policies from the vested interests of the industry. The world can learn from the COVID-19 pandemic to better prepare for future health emergencies of international concern. In light of the impact of tobacco on the COVID-19 pandemic, it is imperative that tobacco control remains a central component in pandemic preparedness and response plans.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dalmau</LastName><ForeName>Regina</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0112-4382</Identifier><AffiliationInfo><Affiliation>University Hospital La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Abdullah M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Monika</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9987-3933</Identifier><AffiliationInfo><Affiliation>Public Health Foundation of India, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>University College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianco</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Frank Foundation for International Health, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaalema</LastName><ForeName>Diann E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0002-6463-9925</Identifier><AffiliationInfo><Affiliation>University of Texas Medical Branch, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goma</LastName><ForeName>Fastone M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Centre for Primary Care Research, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Hospital Organization Kyoto Medical Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komiyama</LastName><ForeName>Maki</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8827-3315</Identifier><AffiliationInfo><Affiliation>National Hospital Organization Kyoto Medical Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez R&#xed;os</LastName><ForeName>M&#xf3;nica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4456-6631</Identifier><AffiliationInfo><Affiliation>University of Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Research Institute of Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willett</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>American Heart Association, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yunshu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>World Heart Federation, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Glob Heart</MedlineTA><NlmUniqueID>101584391</NlmUniqueID><ISSNLinking>2211-8160</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064424" MajorTopicYN="Y">Tobacco Use</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Tobacco</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>7</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38973985</ArticleId><ArticleId IdType="pmc">PMC11225561</ArticleId><ArticleId IdType="doi">10.5334/gh.1334</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Institute for Health Metrics and Evaluation. GBD Compare. Glob Burd Dis. 2019. [cited 2023 September 1]. Available from: https://vizhub.healthdata.org/gbd-compare/.</Citation></Reference><Reference><Citation>National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking&#x2014;50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">24455788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirvonen E, Karlsson A, Saaresranta T, Laitinen T. Documentation of the patient&#x2019;s smoking status in common chronic diseases &#x2013; analysis of medical narrative reports using the ULMFiT based text classification. Eur Clin Respir J. 2021; 8: 2004664. DOI: 10.1080/20018525.2021.2004664</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20018525.2021.2004664</ArticleId><ArticleId IdType="pmc">PMC8635564</ArticleId><ArticleId IdType="pubmed">34868489</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Framework Convention on Tobacco Control, Conference of the Parties, Ninth Session. Decision: Declaration on WHO FCTC and Recovery from the COVID-19 Pandemic 2021.</Citation></Reference><Reference><Citation>Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J Med Virol. 2021; 93: 1045&#x2013;1056. DOI: 10.1002/jmv.26389</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26389</ArticleId><ArticleId IdType="pmc">PMC7436545</ArticleId><ArticleId IdType="pubmed">32749705</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91&#x2013;95. DOI: 10.1016/j.ijid.2020.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.017</ArticleId><ArticleId IdType="pmc">PMC7194638</ArticleId><ArticleId IdType="pubmed">32173574</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5: 811. DOI: 10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MO, Banerjee A. Long COVID and cardiovascular disease: a learning health system approach. Nat Rev Cardiol. 2022; 19: 287&#x2013;8. DOI: 10.1038/s41569-022-00697-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-022-00697-7</ArticleId><ArticleId IdType="pmc">PMC8943785</ArticleId><ArticleId IdType="pubmed">35332308</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain U. Effect of COVID-19 on the Organs. Cureus. 2020; 12: e9540. DOI: 10.7759/cureus.9540</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.9540</ArticleId><ArticleId IdType="pmc">PMC7470660</ArticleId><ArticleId IdType="pubmed">32905500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukassen S, Chua RL, Trefzer T, Kahn NC, Schneider MA, Muley T, et al. SARS -CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. EMBO J. 2020; 39: e105114. DOI: 10.15252/embj.20105114</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.20105114</ArticleId><ArticleId IdType="pmc">PMC7232010</ArticleId><ArticleId IdType="pubmed">32246845</ArticleId></ArticleIdList></Reference><Reference><Citation>Komiyama M, Hasegawa K. Anticoagulant therapy for patients with coronavirus disease 2019: urgent need for enhanced awareness. Eur Cardiol Rev. 2020; 15: e58. DOI: 10.15420/ecr.2020.24</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2020.24</ArticleId><ArticleId IdType="pmc">PMC7479536</ArticleId><ArticleId IdType="pubmed">32944087</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Smoking and COVID-19: scientific brief. World Health Organ 2020. [cited 2023 September 1]. Available from: https://www.who.int/news-room/commentaries/detail/smoking-and-covid-19.</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control. Coronavirus Disease 2019 (COVID-19) Pandemic: Increased Transmission in the EU/EEA and the UK &#x2013; Seventh Update 2020.</Citation></Reference><Reference><Citation>Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020; 253: 117723. DOI: 10.1016/j.lfs.2020.117723</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117723</ArticleId><ArticleId IdType="pmc">PMC7194533</ArticleId><ArticleId IdType="pubmed">32360126</ArticleId></ArticleIdList></Reference><Reference><Citation>Malakan Rad E, Momtazmanesh S. COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy. Egypt Heart J EHJ Off Bull Egypt Soc Cardiol. 2022; 74: 44. DOI: 10.1186/s43044-022-00282-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43044-022-00282-w</ArticleId><ArticleId IdType="pmc">PMC9152834</ArticleId><ArticleId IdType="pubmed">35639214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezati S, Velliou M, Ventoulis I, Simitsis P, Parissis J, Polyzogopoulou E. Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications. Heart Fail Rev. 2023; 28: 893&#x2013;904. DOI: 10.1007/s10741-023-10303-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-023-10303-8</ArticleId><ArticleId IdType="pmc">PMC9999079</ArticleId><ArticleId IdType="pubmed">36897491</ArticleId></ArticleIdList></Reference><Reference><Citation>Komiyama M, Hasegawa K, Matsumori A. Dilated cardiomyopathy risk in patients with coronavirus disease 2019: how to identify and characterise it early? Eur Cardiol Rev. 2020; 15: e49. DOI: 10.15420/ecr.2020.17</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2020.17</ArticleId><ArticleId IdType="pmc">PMC7277785</ArticleId><ArticleId IdType="pubmed">32536978</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. Am J Hypertens. 2015; 28: 1295&#x2013;1302. DOI: 10.1093/ajh/hpv047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpv047</ArticleId><ArticleId IdType="pmc">PMC4612342</ArticleId><ArticleId IdType="pubmed">25911639</ArticleId></ArticleIdList></Reference><Reference><Citation>Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. Glob Heart. 2015; 10: 99. DOI: 10.1016/j.gheart.2015.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gheart.2015.04.003</ArticleId><ArticleId IdType="pubmed">26213297</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora M, ElSayed A, Beger B, Naidoo P, Shilton T, Jain N, et al. The impact of alcohol consumption on cardiovascular health: myths and measures. Glob Heart. 2022; 17: 45. DOI: 10.5334/gh.1132</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.1132</ArticleId><ArticleId IdType="pmc">PMC9306675</ArticleId><ArticleId IdType="pubmed">36051324</ArticleId></ArticleIdList></Reference><Reference><Citation>Santomauro DF, Mantilla Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet. 2021; 398: 1700&#x2013;1712. DOI: 10.1016/S0140-6736(21)02143-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02143-7</ArticleId><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations. Policy brief: COVID-19 and the need for action on mental health 2020.</Citation></Reference><Reference><Citation>United Nations. UN leads call to protect most vulnerable from mental health crisis during and after COVID-19. UN News 2020. [cited 2023 September 1]. Available from: https://news.un.org/en/story/2020/05/1063882.</Citation></Reference><Reference><Citation>Czeisler M&#xc9;, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic &#x2014; United States, June 24&#x2013;30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 1049&#x2013;1057. DOI: 10.15585/mmwr.mm6932a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6932a1</ArticleId><ArticleId IdType="pmc">PMC7440121</ArticleId><ArticleId IdType="pubmed">32790653</ArticleId></ArticleIdList></Reference><Reference><Citation>NHK. Suicide rates have reported a staggering 40% increase from the previous year, among women in particular. NHK 2020. [cited 2023 September 1]. Available from: https://www3.nhk.or.jp/news/html/20201110/k10012704501000.html.</Citation></Reference><Reference><Citation>Starcke K, Brand M. Decision making under stress: A selective review. Neurosci Biobehav Rev. 2012; 36: 1228&#x2013;1248. DOI: 10.1016/j.neubiorev.2012.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2012.02.003</ArticleId><ArticleId IdType="pubmed">22342781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008; 1141: 105&#x2013;130. DOI: 10.1196/annals.1441.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1441.030</ArticleId><ArticleId IdType="pmc">PMC2732004</ArticleId><ArticleId IdType="pubmed">18991954</ArticleId></ArticleIdList></Reference><Reference><Citation>Komiyama M, Hasegawa K. Coronavirus disease 2019: psychological stress and cardiovascular diseases. Eur Cardiol. 2021; 16: e33. DOI: 10.15420/ecr.2021.10</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2021.10</ArticleId><ArticleId IdType="pmc">PMC8477172</ArticleId><ArticleId IdType="pubmed">34603513</ArticleId></ArticleIdList></Reference><Reference><Citation>Patwardhan P. COVID-19: Risk of increase in smoking rates among England&#x2019;s 6 million smokers and relapse among England&#x2019;s 11 million ex-smokers. BJGP Open. 2020; 4: bjgpopen20X101067. DOI: 10.3399/bjgpopen20X101067</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101067</ArticleId><ArticleId IdType="pmc">PMC7330228</ArticleId><ArticleId IdType="pubmed">32265183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bommel&#xe9; J, Hopman P, Hipple Walters B, Geboers C, Croes E, Fong G, et al. The double-edged relationship between COVID-19 stress and smoking: Implications for smoking cessation. Tob Induc Dis. 2020; 18. DOI: 10.18332/tid/125580</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/125580</ArticleId><ArticleId IdType="pmc">PMC7386200</ArticleId><ArticleId IdType="pubmed">32733178</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D. The psychosocial impact of the COVID-19 pandemic on changes in smoking behavior: Evidence from a nationwide survey in the UK. Tob Prev Cessat. 2020; 6: 1&#x2013;5. DOI: 10.18332/tpc/126976</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tpc/126976</ArticleId><ArticleId IdType="pmc">PMC7643580</ArticleId><ArticleId IdType="pubmed">33163705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley RC, Oliver AC, Snow MB, Bunn JY, Barrows AJ, Tidey JW, et al. The impact of the Covid-19 pandemic on smoking among vulnerable populations. Nicotine Tob Res. 2023; 25: 282&#x2013;290. DOI: 10.1093/ntr/ntac135</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntac135</ArticleId><ArticleId IdType="pmc">PMC9384158</ArticleId><ArticleId IdType="pubmed">35605264</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research and Development Agency, National Cancer Center. Survey report on the new coronavirus and tobacco 2021.</Citation></Reference><Reference><Citation>Rigotti NA, Chang Y, Regan S, Lee S, Kelley JHK, Davis E, et al. Cigarette smoking and risk perceptions during the COVID-19 pandemic reported by recently hospitalized participants in a smoking cessation trial. J Gen Intern Med. 2021; 36: 3786&#x2013;3793. DOI: 10.1007/s11606-021-06913-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-06913-3</ArticleId><ArticleId IdType="pmc">PMC8183588</ArticleId><ArticleId IdType="pubmed">34100230</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyman AL, Spears CA, Churchill V, Do VV, Henderson KC, Massey ZB, et al. Associations between COVID-19 risk perceptions and smoking and quitting behavior among U.S. adults. Addict Behav Rep. 2021; 14: 100394. DOI: 10.1016/j.abrep.2021.100394</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abrep.2021.100394</ArticleId><ArticleId IdType="pmc">PMC8626346</ArticleId><ArticleId IdType="pubmed">34869823</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold AK, Hoyt DL, Milligan M, Hiserodt ML, Samora J, Leyro TM, et al. The role of fear of COVID-19 in motivation to quit smoking and reductions in cigarette smoking: a preliminary investigation of at-risk cigarette smokers. Cogn Behav Ther. 2021; 50: 295&#x2013;304. DOI: 10.1080/16506073.2021.1877340</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16506073.2021.1877340</ArticleId><ArticleId IdType="pmc">PMC8140981</ArticleId><ArticleId IdType="pubmed">33605833</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Pulse survey on continuity of essential health services during the COVID-19 pandemic - interim report: 27 August 2020. Geneva, Switzerland: World Health Organization; 2020.</Citation></Reference><Reference><Citation>Baggio S, Vernaz N, Spechbach H, Salamun J, Jacquerioz F, Stringhini S, et al. Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic. Prev Med. 2021; 150: 106696. DOI: 10.1016/j.ypmed.2021.106696</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2021.106696</ArticleId><ArticleId IdType="pmc">PMC8220858</ArticleId><ArticleId IdType="pubmed">34174252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. The Lancet. 2020; 396: 381&#x2013;389. DOI: 10.1016/S0140-6736(20)31356-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31356-8</ArticleId><ArticleId IdType="pmc">PMC7429983</ArticleId><ArticleId IdType="pubmed">32679111</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippo O, D&#x2019;Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. 2020; 383: 88&#x2013;89. DOI: 10.1056/NEJMc2009166</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009166</ArticleId><ArticleId IdType="pmc">PMC7224608</ArticleId><ArticleId IdType="pubmed">32343497</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca G, Algowhary M, Uguz B, Oliveira DC, Ganyukov V, Zimbakov Z, et al. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction. Heart Br Card Soc. 2022; 108: 458&#x2013;466. DOI: 10.1136/heartjnl-2021-319750</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-319750</ArticleId><ArticleId IdType="pubmed">34711661</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Leor O, Cid-&#xc1;lvarez B, P&#xe9;rez de Prado A, Rossello X, Ojeda S, Serrador A, et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Espanola Cardiol Engl Ed. 2020; 73: 994&#x2013;1002. DOI: 10.1016/j.rec.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7834732</ArticleId><ArticleId IdType="pubmed">32917566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JT, Griffiths S, Choi KC, Tsui HY. Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1 N1 pandemic in Hong Kong. BMC Infect Dis. 2010; 10: 139. DOI: 10.1186/1471-2334-10-139</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-10-139</ArticleId><ArticleId IdType="pmc">PMC2891756</ArticleId><ArticleId IdType="pubmed">20509887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghisi GL de M, Xu Z, Liu X, Mola A, Gallagher R, Babu AS, et al. Impacts of the COVID-19 pandemic on cardiac rehabilitation delivery around the world. Glob Heart. 2021; 16: 43. DOI: 10.5334/gh.939</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.939</ArticleId><ArticleId IdType="pmc">PMC8195253</ArticleId><ArticleId IdType="pubmed">34211829</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese MS, Beatty AL, Song Y, Xu J, Sperling LS, Fonarow GC, et al. Cardiac rehabilitation and the COVID-19 pandemic: persistent declines in cardiac rehabilitation participation and access among US medicare beneficiaries. Circ Cardiovasc Qual Outcomes. 2022; 15. DOI: 10.1161/CIRCOUTCOMES.122.009618</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.122.009618</ArticleId><ArticleId IdType="pmc">PMC9749950</ArticleId><ArticleId IdType="pubmed">36314139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandi P, Asare S, Majmundar A, Xue Z, Han X, Westmaas JL, et al. Changes in smoking cessation&#x2013;related behaviors among US adults during the COVID-19 pandemic. JAMA Netw Open. 2022; 5: e2225149. DOI: 10.1001/jamanetworkopen.2022.25149</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.25149</ArticleId><ArticleId IdType="pmc">PMC9344362</ArticleId><ArticleId IdType="pubmed">35913738</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettigrew S, Jun M, Roberts I, Bullen C, Nallaiah K, Rodgers A. Preferences for tobacco cessation information and support during Covid-19. J Addict Med. 2020; 14: e362&#x2013;365. DOI: 10.1097/ADM.0000000000000743</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ADM.0000000000000743</ArticleId><ArticleId IdType="pubmed">32941292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayhan Tetik B, Gedik Tekinemre I, Ta&#x15f; S. The effect of the COVID-19 Pandemic on smoking cessation success. J Community Health. 2021; 46: 471&#x2013;475. DOI: 10.1007/s10900-020-00880-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10900-020-00880-2</ArticleId><ArticleId IdType="pmc">PMC7340767</ArticleId><ArticleId IdType="pubmed">32643078</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboueshia M, Hussein MH, Attia AS, Swinford A, Miller P, Omar M, et al. Cancer and COVID-19: analysis of patient outcomes. Future Oncol. 2021; 17: 3499&#x2013;3510. DOI: 10.2217/fon-2021-0121</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fon-2021-0121</ArticleId><ArticleId IdType="pmc">PMC8284249</ArticleId><ArticleId IdType="pubmed">34263660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Patti G, Hayden E, Azzolina D, Pirisi M, Acquaviva A, et al. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep. 2020; 10: 20731. DOI: 10.1038/s41598-020-77698-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77698-4</ArticleId><ArticleId IdType="pmc">PMC7692524</ArticleId><ArticleId IdType="pubmed">33244144</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharthy A, Aletreby W, Faqihi F, Balhamar A, Alaklobi F, Alanezi K, et al. Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study. J Epidemiol Glob Health. 2020; 11: 98. DOI: 10.2991/jegh.k.200928.001</Citation><ArticleIdList><ArticleId IdType="doi">10.2991/jegh.k.200928.001</ArticleId><ArticleId IdType="pmc">PMC7958266</ArticleId><ArticleId IdType="pubmed">33095982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly G, Petti S, Noah N. Covid-19, non-Covid-19 and excess mortality rates not comparable across countries. Epidemiol Infect. 2021; 149: e176. DOI: 10.1017/S0950268821001850</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821001850</ArticleId><ArticleId IdType="pmc">PMC8365039</ArticleId><ArticleId IdType="pubmed">34338184</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro AC, Suri R, Emeruwa IO, Stretch RJ, Cortes-Lopez RY, Sherman A, et al. Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study. PLOS ONE. 2020; 15: e0238552. DOI: 10.1371/journal.pone.0238552</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238552</ArticleId><ArticleId IdType="pmc">PMC7755188</ArticleId><ArticleId IdType="pubmed">33351817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari BL, Ferreira CG, Menezes M, De Marchi P, Canedo J, Melo ACD, et al. Determinants of COVID-19 mortality in patients with cancer from a community oncology practice in Brazil. JCO Glob Oncol. 2021: 46&#x2013;55. DOI: 10.1200/GO.20.00444</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/GO.20.00444</ArticleId><ArticleId IdType="pmc">PMC8081500</ArticleId><ArticleId IdType="pubmed">33434066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayhan M, Odabas H, Turan N, Ozyukseler DT, Kostek O, Alkan G, et al. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center&#x2019;s experience. J Chemother. 2021; 33: 499&#x2013;508. DOI: 10.1080/1120009X.2021.1923153</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1120009X.2021.1923153</ArticleId><ArticleId IdType="pubmed">34032198</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A, Dhingra R, Al-Mulki J, Hassoun M, Alexis N. Questioning the sex-specific differences in the association of smoking on the survival rate of hospitalized COVID-19 patients. PLOS ONE. 2021; 16: e0255692. DOI: 10.1371/journal.pone.0255692</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255692</ArticleId><ArticleId IdType="pmc">PMC8341532</ArticleId><ArticleId IdType="pubmed">34351990</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLOS ONE. 2020; 15: e0233147. DOI: 10.1371/journal.pone.0233147</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233147</ArticleId><ArticleId IdType="pmc">PMC7213702</ArticleId><ArticleId IdType="pubmed">32392262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacedonia D, Scioscia G, Santomasi C, Fuso P, Carpagnano GE, Portacci A, et al. Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients. Sci Rep. 2021; 11: 19251. DOI: 10.1038/s41598-021-98749-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98749-4</ArticleId><ArticleId IdType="pmc">PMC8478875</ArticleId><ArticleId IdType="pubmed">34584165</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul DJ, Esenwa C, Haranhalli N, Unda SR, De La Garza Ramos R, Dardick J, et al. Predictors of mortality for patients with COVID-19 and large vessel occlusion. Interv Neuroradiol. 2020; 26: 623&#x2013;628. DOI: 10.1177/1591019920954603</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1591019920954603</ArticleId><ArticleId IdType="pmc">PMC7586005</ArticleId><ArticleId IdType="pubmed">32862753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KS, Narasimhan B, Sheehan J, Wu L, Fung JY. Controversy over smoking in COVID-19&#x2014;a real world experience in New York city. J Med Virol. 2021; 93: 4537&#x2013;4543. DOI: 10.1002/jmv.26738</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26738</ArticleId><ArticleId IdType="pubmed">33325049</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskaran V, Murray RL, Hunter A, Lim WS, McKeever TM. Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis. PLOS ONE. 2019; 14: e0220204. DOI: 10.1371/journal.pone.0220204</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0220204</ArticleId><ArticleId IdType="pmc">PMC6638981</ArticleId><ArticleId IdType="pubmed">31318967</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Ran J, Mak Y-W, Suen LK-P, Lee PH, Peiris JSM, et al. Smoking and influenza-associated morbidity and mortality: a systematic review and meta-analysis. Epidemiology. 2019; 30: 405&#x2013;417. DOI: 10.1097/EDE.0000000000000984</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000984</ArticleId><ArticleId IdType="pubmed">30789425</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y, Rivas-Santiago CE, L&#xf3;pez JA, Mendoza-Almanza G, Hernandez-Pando R. Tuberculosis and cigarette smoke exposure: An update of in vitro and in vivo studies. Exp Lung Res. 2018; 44: 113&#x2013;126. DOI: 10.1080/01902148.2018.1444824</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01902148.2018.1444824</ArticleId><ArticleId IdType="pubmed">29565741</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyunoya T, Mebratu Y, Contreras A, Delgado M, Chand HS, Tesfaigzi Y. Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung. Am J Respir Cell Mol Biol. 2014; 50: 471&#x2013;482. DOI: 10.1165/rcmb.2013-0348TR</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2013-0348TR</ArticleId><ArticleId IdType="pmc">PMC4068939</ArticleId><ArticleId IdType="pubmed">24111585</ArticleId></ArticleIdList></Reference><Reference><Citation>Benowitz NL, Goniewicz ML, Halpern-Felsher B, Krishnan-Sarin S, Ling PM, O&#x2019;Connor RJ, et al. Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research. Lancet Respir Med. 2022; 10: 900&#x2013;15. DOI: 10.1016/S2213-2600(22)00182-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00182-5</ArticleId><ArticleId IdType="pmc">PMC9381032</ArticleId><ArticleId IdType="pubmed">35985357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health, Labour and Welfare of Japan. Benefits of quitting smoking. E-Heal 2020. [cited 2023 October 3]. Available from: https://www.e-healthnet.mhlw.go.jp/information/tobacco/t-08-001.html.</Citation></Reference><Reference><Citation>Lung Foundation Australia. Quitting smoking. Lung Found Aust. n.d. [cited 2023 October 3]. Available from: https://lungfoundation.com.au/lung-health/protecting-your-lungs/quitting-smoking/.</Citation></Reference><Reference><Citation>Rainer T, Smit D, Cameron P. Smoking and severe acute respiratory syndrome. Hong Kong J Emerg Med. 2004; 11: 143&#x2013;145. DOI: 10.1177/102490790401100303</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/102490790401100303</ArticleId></ArticleIdList></Reference><Reference><Citation>Alraddadi BM, Watson JT, Almarashi A, Abedi GR, Turkistani A, Sadran M, et al. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis. 2016; 22: 49&#x2013;55. DOI: 10.3201/eid2201.151340</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2201.151340</ArticleId><ArticleId IdType="pmc">PMC4696714</ArticleId><ArticleId IdType="pubmed">26692185</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam H-S, Park JW, Ki M, Yeon M-Y, Kim J, Kim SW. High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. Int J Infect Dis. 2017; 58: 37&#x2013;42. DOI: 10.1016/j.ijid.2017.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2017.02.008</ArticleId><ArticleId IdType="pmc">PMC7110480</ArticleId><ArticleId IdType="pubmed">28223175</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. 2021; 116: 1319&#x2013;1368. DOI: 10.1111/add.15276</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.15276</ArticleId><ArticleId IdType="pmc">PMC7590402</ArticleId><ArticleId IdType="pubmed">33007104</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow N, Fleming-Dutra K, Gierke R, Hall A, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 &#x2014; United States, February 12&#x2013;March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 382&#x2013;386. DOI: 10.15585/mmwr.mm6913e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6913e2</ArticleId><ArticleId IdType="pmc">PMC7119513</ArticleId><ArticleId IdType="pubmed">32240123</ArticleId></ArticleIdList></Reference><Reference><Citation>Samet JM. Tobacco products and the risks of SARS-CoV-2 infection and COVID-19. Nicotine Tob Res. 2020; 22: S93&#x2013;S95. DOI: 10.1093/ntr/ntaa187</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntaa187</ArticleId><ArticleId IdType="pmc">PMC7953960</ArticleId><ArticleId IdType="pubmed">33320258</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Westen-Lagerweij NA, Meijer E, Meeuwsen EG, Chavannes NH, Willemsen MC, Croes EA. Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth. Npj Prim Care Respir Med. 2021; 31: 10. DOI: 10.1038/s41533-021-00223-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41533-021-00223-1</ArticleId><ArticleId IdType="pmc">PMC7910565</ArticleId><ArticleId IdType="pubmed">33637750</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708&#x2013;1720. DOI: 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyara M, Tubach F, Pourcher V, Mor&#xe9;lot-Panzini C, Pernet J, Haroche J, et al. Lower rate of daily smokers with symptomatic COVID-19: a monocentric self-report of smoking habit study. Front Med. 2022; 8: 668995. DOI: 10.3389/fmed.2021.668995</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.668995</ArticleId><ArticleId IdType="pmc">PMC8766759</ArticleId><ArticleId IdType="pubmed">35071251</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). World Health Organ 2022. [cited 2023 September 1]. Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:~:text=Definition,months%20with%20no%20other%20explanation.</Citation></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022; 376: e068993. DOI: 10.1136/bmj-2021-068993</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis Lond Engl. 2021; 53: 737&#x2013;754. DOI: 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022; 28: 1706&#x2013;1714. DOI: 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MA, Hossain KMA, Saunders K, Uddin Z, Walton LM, Raigangar V, et al. Prevalence of long COVID symptoms in Bangladesh: a prospective inception cohort study of COVID-19 survivors. BMJ Glob Health. 2021; 6: e006838. DOI: 10.1136/bmjgh-2021-006838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-006838</ArticleId><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022; 13: 1957. DOI: 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul E, Fancourt D. Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: a longitudinal analysis of 1581 UK adults. BMC Public Health. 2022; 22: 1716. DOI: 10.1186/s12889-022-14123-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14123-7</ArticleId><ArticleId IdType="pmc">PMC9462889</ArticleId><ArticleId IdType="pubmed">36085055</ArticleId></ArticleIdList></Reference><Reference><Citation>Takakura K, Suka M, Kajihara M, Koido S. Clinical features, therapeutic outcomes, and recovery period of long COVID. J Med Virol. 2023; 95: e28316. DOI: 10.1002/jmv.28316</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28316</ArticleId><ArticleId IdType="pmc">PMC10108287</ArticleId><ArticleId IdType="pubmed">36412057</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Tao Z-W, Wang L, Yuan M-L, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020; 133: 1032&#x2013;1038. DOI: 10.1097/CM9.0000000000000775</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000775</ArticleId><ArticleId IdType="pmc">PMC7147279</ArticleId><ArticleId IdType="pubmed">32118640</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbe CO, Ngobese SP, Barca H, Crosbie E. &#x201c;Are they trying to control us people?&#x201d;: News media coverage of COVID-19 lockdown tobacco sales ban in South Africa. PLOS ONE. 2022; 17: e0278888. DOI: 10.1371/journal.pone.0278888</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278888</ArticleId><ArticleId IdType="pmc">PMC9744309</ArticleId><ArticleId IdType="pubmed">36508420</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Peto R, Zhou M, Iona A, Smith M, Yang L, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. The Lancet. 2015; 386: 1447&#x2013;1456. DOI: 10.1016/S0140-6736(15)00340-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00340-2</ArticleId><ArticleId IdType="pmc">PMC4691901</ArticleId><ArticleId IdType="pubmed">26466050</ArticleId></ArticleIdList></Reference><Reference><Citation>The tobacco atlas. Challenges: COVID-19. Tob Atlas 2022. [cited 2023 September 1]. Available from: https://tobaccoatlas.org/challenges/covid-19/.</Citation></Reference><Reference><Citation>Vardavas C, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020; 18. DOI: 10.18332/tid/119324</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/119324</ArticleId><ArticleId IdType="pmc">PMC7083240</ArticleId><ArticleId IdType="pubmed">32206052</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobacco Reporter. BAT Unaffected by Virus Outbreak. Tob Report 2020. [cited 2023 September 1]. Available from: https://tobaccoreporter.com/2020/03/19/bat-unaffected-by-outbreak/.</Citation></Reference><Reference><Citation>Williams S. Coronavirus income stocks: 7 high-yield dividend stocks to buy right now. Nasdaq 2020. [cited 2023 September 1]. Available from: https://www.nasdaq.com/articles/coronavirus-income-stocks%3A-7-high-yield-dividend-stocks-to-buy-right-now-2020-03-23.</Citation></Reference><Reference><Citation>Tobacco tactics. Kenya- Country Profile. Tob Tactics 2021. [cited 2023 September 1]. Available from: https://tobaccotactics.org/article/kenya-country-profile/.</Citation></Reference><Reference><Citation>Huber L, Cuadrado U, Fernandez-Megina R, Raw M, Marquizo AB, Romeo-Stuppy K. The impact of COVID-19 on the WHO FCTC, cessation, and tobacco policy. Tob Induc Dis. 2020; 18: 102. DOI: 10.18332/tid/130779</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/130779</ArticleId><ArticleId IdType="pmc">PMC7731301</ArticleId><ArticleId IdType="pubmed">33324139</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DT-H. Tobacco control measures in COVID-19 recovery: an opportune time to restore equity and planetary health. Environ Health Prev Med. 2022; 27: 15. DOI: 10.1265/ehpm.21-00027</Citation><ArticleIdList><ArticleId IdType="doi">10.1265/ehpm.21-00027</ArticleId><ArticleId IdType="pmc">PMC9251628</ArticleId><ArticleId IdType="pubmed">35354709</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Framework Convention on Tobacco Control, World Health Organization. WHO framework convention on tobacco control 2003: 36.</Citation></Reference><Reference><Citation>El-Awa F, Fraser CP, Adib K, Hammerich A, Abdel Latif N, Fayokun R, et al. The necessity of continuing to ban tobacco use in public places post-COVID-19. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. 2020; 26: 630&#x2013;632. DOI: 10.26719/emhj.20.071</Citation><ArticleIdList><ArticleId IdType="doi">10.26719/emhj.20.071</ArticleId><ArticleId IdType="pubmed">32621493</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-R&#xe1;bago Y, Cabezas-Rodr&#xed;guez A, Mart&#xed;n U. Social inequalities in health determinants in Spanish children during the COVID-19 lockdown. Int J Environ Res Public Health. 2021; 18: 4087. DOI: 10.3390/ijerph18084087</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084087</ArticleId><ArticleId IdType="pmc">PMC8069937</ArticleId><ArticleId IdType="pubmed">33924441</ArticleId></ArticleIdList></Reference><Reference><Citation>Havranek EP, Mujahid MS, Barr DA, Blair IV, Cohen MS, Cruz-Flores S, et al. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015; 132: 873&#x2013;898. DOI: 10.1161/CIR.0000000000000228</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000228</ArticleId><ArticleId IdType="pubmed">26240271</ArticleId></ArticleIdList></Reference><Reference><Citation>Roger VL. Medicine and society: social determinants of health and cardiovascular disease. Eur Heart J. 2020; 41: 1179&#x2013;1181. DOI: 10.1093/eurheartj/ehaa134</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa134</ArticleId><ArticleId IdType="pubmed">32163133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee GH, Aris T, Rarick J, Irimie S. Social determinants of health and tobacco use in five low and middle-income countries&#x2014;results from the Global Adult Tobacco Survey (GATS), 2011&#x2013;2012. Asian Pac J Cancer Prev APJCP. 2016; 17: 1269&#x2013;1276. DOI: 10.7314/APJCP.2016.17.3.1269</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2016.17.3.1269</ArticleId><ArticleId IdType="pubmed">27039759</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahim S, Jawad M. Socioeconomic differences in smoking in Jordan, Lebanon, Syria, and Palestine: A cross-sectional analysis of national surveys. PloS One. 2018; 13: e0189829. DOI: 10.1371/journal.pone.0189829</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0189829</ArticleId><ArticleId IdType="pmc">PMC5790213</ArticleId><ArticleId IdType="pubmed">29381734</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Regional Office for South-East Asia. Factsheet 2018: India 2018.</Citation></Reference><Reference><Citation>Siddiqi K, Husain S, Vidyasagaran A, Readshaw A, Mishu MP, Sheikh A. Global burden of disease due to smokeless tobacco consumption in adults: an updated analysis of data from 127 countries. BMC Med. 2020; 18: 222. DOI: 10.1186/s12916-020-01677-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01677-9</ArticleId><ArticleId IdType="pmc">PMC7422596</ArticleId><ArticleId IdType="pubmed">32782007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tata Institute of Social Sciences, Ministry of Health and Family Welfare of India. Global adult tobacco survey&#x2014;second round&#x2014;India 2016&#x2013;17 Report. New Delhi: Ministry of Health and Family Welfare of India; 2018.</Citation></Reference><Reference><Citation>World Health Organization. Coronavirus disease (COVID-19): tobacco. World Health Organ 2022. [cited 2023 September 1]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-tobacco.</Citation></Reference><Reference><Citation>Arora M, Nazar GP, Sharma N, Jain N, Davidson F, Mohan S, et al. COVID-19 and tobacco cessation: lessons from India. Public Health. 2022; 202: 93&#x2013;99. DOI: 10.1016/j.puhe.2021.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8633921</ArticleId><ArticleId IdType="pubmed">34933205</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N, Chopra M, Bauld L, Nazar G, Joshi N, Chugh A, et al. Impact of a tobacco sales ban on the frequency of tobacco consumption in India during the COVID-19 pandemic. Tob Induc Dis. 2023; 21: 1&#x2013;6. DOI: 10.18332/tid/161855</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/161855</ArticleId><ArticleId IdType="pmc">PMC10141826</ArticleId><ArticleId IdType="pubmed">37123348</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Framework Convention on Tobacco Control. 2021 global progress report on implementation of the WHO Framework Convention on Tobacco Control. Geneva: World Health Organization; 2022.</Citation></Reference><Reference><Citation>Burki TK. Tobacco industry influence during the COVID-19 pandemic. Lancet Oncol. 2021; 22: 1658. DOI: 10.1016/S1470-2045(21)00644-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(21)00644-6</ArticleId><ArticleId IdType="pmc">PMC8575466</ArticleId><ArticleId IdType="pubmed">34762830</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Framework Convention on Tobacco Control. Guidelines for implementation of Article 5.3 2013.</Citation></Reference><Reference><Citation>WHO Framework Convention on Tobacco Control. FCTC&#x2014;overview. WHO Framew Conv Tob Control 2023. [cited 2023 September 1]. Available from: https://fctc.who.int/who-fctc/overview.</Citation></Reference><Reference><Citation>Lee JJ, Wang MP, Yang SC. Will the tobacco industry ultimately triumph in the midst of COVID-19 pandemic?: A call for nurses&#x2019; action in tobacco control. Int J Nurs Stud. 2021; 115: 103726. DOI: 10.1016/j.ijnurstu.2020.103726</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2020.103726</ArticleId><ArticleId IdType="pmc">PMC7382356</ArticleId><ArticleId IdType="pubmed">32778333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>